These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass. Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136 [TBL] [Abstract][Full Text] [Related]
4. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot. Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293 [TBL] [Abstract][Full Text] [Related]
5. In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass. Barnette RE; Shupak RC; Pontius J; Rao AK Anesth Analg; 1988 Jan; 67(1):57-60. PubMed ID: 3257361 [TBL] [Abstract][Full Text] [Related]
6. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass. Arén C; Feddersen K; Rådegran K J Thorac Cardiovasc Surg; 1987 Oct; 94(4):539-41. PubMed ID: 3309479 [TBL] [Abstract][Full Text] [Related]
7. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays. Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195 [TBL] [Abstract][Full Text] [Related]
8. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery]. Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulant monitoring and neutralization during open heart surgery--a rapid method for measuring heparin and calculating safe reduced protamine doses. Umlas J; Taff RH; Gauvin G; Swierk P Anesth Analg; 1983 Dec; 62(12):1095-9. PubMed ID: 6650893 [TBL] [Abstract][Full Text] [Related]
11. [The effect of antithrombin iii concentrations during cardiopulmonary surgery]. Sonzogni V; Bellavita P; Carrara B; Cossolini M; Ferri F; Fabretti F; Mamprin F; Pelliccioli I Minerva Anestesiol; 2000; 66(1-2):17-23. PubMed ID: 10736978 [TBL] [Abstract][Full Text] [Related]
12. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery. Zaidan JR; Johnson S; Brynes R; Monroe S; Guffin AV Anesth Analg; 1986 Apr; 65(4):377-80. PubMed ID: 3954111 [TBL] [Abstract][Full Text] [Related]
13. Changes in antithrombin, antiplasmin, and plasminogen during and after cardiopulmonary bypass. Wolk LA; Wilson RF; Burdick M; Selik N; Brown J; Starricco A; Mammen EF Am Surg; 1985 Jun; 51(6):309-13. PubMed ID: 3873197 [TBL] [Abstract][Full Text] [Related]
14. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass. Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update. Despotis GJ; Joist JH J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245 [TBL] [Abstract][Full Text] [Related]
16. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study. Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778 [TBL] [Abstract][Full Text] [Related]
17. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation. Hashimoto K; Yamagishi M; Sasaki T; Nakano M; Kurosawa H Ann Thorac Surg; 1994 Sep; 58(3):799-804; discussion 804-5. PubMed ID: 7944706 [TBL] [Abstract][Full Text] [Related]
18. Factor VIIa-Antithrombin complexes during cardiac surgery using cardiopulmonary bypass. Davidson SJ; Woodhams B Int J Lab Hematol; 2011 Dec; 33(6):614-6. PubMed ID: 21569219 [TBL] [Abstract][Full Text] [Related]
19. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery? Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457 [TBL] [Abstract][Full Text] [Related]
20. Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of two techniques. Mabry CD; Thompson BW; Read RC; Campbell GS Surgery; 1981 Nov; 90(5):889-95. PubMed ID: 7302842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]